Evaluation of Sympathetic Activity Effects by the BackBeat Medical Cardiac Neuromodulation Therapy (CNT).

NAUnknownINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 10, 2022

Primary Completion Date

September 30, 2023

Study Completion Date

December 31, 2023

Conditions
Hypertension
Interventions
PROCEDURE

Experimental group

In the setting phase subjects will be in recumbent position. A microneurography needle (0.2mm diameter isolated Tungsten micro-electrode) will be placed under the skin. An identical (not isolated) reference needle tip will be inserted within 2 cm of the first electrode. These are connected to a recording system (ADInstruments PowerLab). Once sympathetic activity can be measured using the needles, a sympathetic specific test will be used to calibrate the measurement and recording system. In the testing phase sequential pacing and CNT delivery will be programmed for a few minutes, the whole procedure expected to last less than 2 hours.

Trial Locations (1)

1122

RECRUITING

Semmelweis University Heart and Vascular Center, Budapest

Sponsors
All Listed Sponsors
lead

BackBeat Medical Inc

INDUSTRY

NCT05462405 - Evaluation of Sympathetic Activity Effects by the BackBeat Medical Cardiac Neuromodulation Therapy (CNT). | Biotech Hunter | Biotech Hunter